The HybridHeart consortium envisions to develop and bring to the clinic a soft biocompatible artificial heart, which can completely replace a patient’s heart in a procedure similar to a heart transplant.
With a budget of almost €5 Million, the EU-funded C3-Cloud project will establish an ICT infrastructure facilitating a collaborative care and cure cloud to enable continuous coordination of patient-centred care activities by a multidisciplinary care team or informal care givers.
The European funded City4Age project aims to make cities more age-friendly. It will create innovative ICT tools and services for early detection of risks related to frailty and of Mild Cognitive Impairments (MCI). The services will be tested in several European cities, as well as in Singapore.
ORCHID will facilitate dialogue towards accelerating the development of prototypes of organs-on-chips (validated cell systems that mimic diseased or healthy human tissue), and the implementation of this technology by a broad group of potential users in science, health care and industry.
A new European Commission study analyses the impact on society of EU-funded Research and Innovation in technology for active and healthy ageing. Which of the projects have had the most influence in Europe over the last 11 years?
The European Commission has published a new booklet showing a few examples where EU support for research and innovation is making a real difference in the lives of citizens and society as a whole. It is aimed at all age groups so everyone can understand the good work EU funding can do.
Asthma has become a major health and economic burden in Europe affecting 30 million Europeans and one quarter of European children. Current therapies are limited to temporary improvements of the conditions of asthmatic patients but none tackle the underlying causes of the disease. There is no cure for asthma and so far no developments are recorded for new cures but what if this complex disease requires out-of-the box thinking?